AI Science Tracker
EN

Key Laboratory of Environmental Medicine Engineering of Ministry of Education

1 discovery from 2024

Discoveries

G6PD and machine learning algorithms as prognostic and diagnostic indicators of liver hepatocellular carcinoma.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: TCGA/ICGC/GEO cohorts and liver-cancer cell lines are used; qRT-PCR, western blot, knockdown, proliferation/migration assays, and classifier tests are reported.

Technology: G6PD expression and machine-learning classifiers are evaluated as diagnostic/prognostic indicators in liver hepatocellular carcinoma, with cell perturbation experiments.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
G6PD expression and machine-learning classifiers are evaluated as diagnostic/prognostic indicators in liver hepatocellular carcinoma, with cell perturbation experiments.
Limitation / still unknown
Cell experiments support biological relevance; retrospective cohorts do not establish clinical performance.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/38297250 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC10829225/unicode · https://pubmed.ncbi.nlm.nih.gov/38297250/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.